Trials / Unknown
UnknownNCT00797784
The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus
A Phase 2 Open Label Study to Assess the Efficacy and Safety of Etanercept (Enbrel®)for the Treatment of Discoid Lupus Erythematosus
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Florida Academic Dermatology Centers · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
A 20 week study to assess the safety and efficacy of etanercept(Enbrel®)for the treatment of Discoid Lupus Erythematosus
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | etanercept(Enbrel®) | etanercept(Enbrel®) 50mgs subcutaneous (SC) injections twice weekly for 20 weeks |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2011-04-01
- Completion
- 2011-04-01
- First posted
- 2008-11-25
- Last updated
- 2010-05-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00797784. Inclusion in this directory is not an endorsement.